In New York, cannabis advocates and businesses are weighing the recent expansion of the state’s tightly regulated medical marijuana program.
Last month, the Department of Health added opioid use, chronic pain and post-traumatic stress disorder (PTSD) to the list of qualifying conditions under the state’s medical marijuana program, which was among several recent improvements to the program, according to Jill Montag, department spokesperson.
On July 12, the department officials published emergency regulations for the opioid replacement policy, adding “any condition for which an opioid could be prescribed as a qualifying condition for medical marijuana,” according to the state’s website.
On top of the newly added qualifying conditions, the Department of Health also greenlit five more manufacturers and dispensaries in the state—and opened the door to home delivery regulation.
“The Department of Health is committed to growing New York’s Medical Marijuana Program responsibly,” Montag told Cannabis Business Times.
The Marijuana Policy Project (MPP) was